8 followers
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.
John Evans
Roivant Sciences
56 followers
CRISPR Therapeutics
11 followers
Denali Therapeutics
5 followers
Quanterix
3 followers
Vir Biotechnology
3 followers
Axsome Therapeutics
2 followers
BioAgilytix
2 followers
Recursion Pharmaceuticals
9 followers
Thermo Fisher Scientific
168 followers
Genentech
150 followers
Gilead Sciences
129 followers
Explore companies